GLIOBLASTOMA MULTIFORME, ADULT
Clinical trials for GLIOBLASTOMA MULTIFORME, ADULT explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME, ADULT trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope in fight against deadly brain cancer
Disease control Recruiting nowThis study is testing whether adding the drug ruxolitinib to the standard treatment (radiation plus temozolomide) works better for people newly diagnosed with glioblastoma, a serious type of brain cancer. About 190 adults will be randomly assigned to receive either the standard t…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scientists use gene therapy to shield patients from Chemo's worst side effects in aggressive brain cancer fight
Disease control Recruiting nowThis trial is testing a new approach for treating a fast-growing brain cancer called glioblastoma. Doctors first collect a patient's own blood stem cells and modify them with a protective gene in the lab. These modified cells are then given back to the patient to help their bone …
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Leland Metheny • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Precision radiation attack on deadly brain cancer
Disease control Recruiting nowThis study is testing a more precise way to deliver radiation to glioblastoma, a fast-growing brain cancer. It focuses on frail patients or those who could not have full surgery. Doctors use a special PET scan to find the most aggressive parts of the tumor and aim a higher radiat…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New radiation 'Smart Bomb' targets deadly brain cancer in global trial
Disease control Recruiting nowThis global Phase 3 trial is testing whether adding a new targeted radiation therapy (TLX101-Tx) to standard chemotherapy (lomustine) works better than chemotherapy alone for adults whose aggressive brain cancer (glioblastoma) has returned for the first time. The new therapy aims…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC